{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:28:11Z","timestamp":1790274491375,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"French Ministry of Health","award":["PHRCI-2016"],"award-info":[{"award-number":["PHRCI-2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00134-022-06872-1","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T02:02:27Z","timestamp":1663120947000},"page":"1563-1572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial"],"prefix":"10.1007","volume":"48","clinical-trial-number":[{"clinical-trial-number":"nct03201575","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-9761","authenticated-orcid":false,"given":"Martin","family":"Cour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kada","family":"Klouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Quenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Schwebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Perinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Amaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ovize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Mewton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the RECO-Sepsis Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Hernu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inesse","family":"Gragueb-Chebib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Baudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Madelaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Coupez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Lautrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auguste","family":"Dargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Thiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"6872_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M, Force SDT (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:775\u2013787. https:\/\/doi.org\/10.1001\/jama.2016.0289","journal-title":"JAMA"},{"issue":"23","key":"6872_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"31","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Jones G, David S, Olariu E, Cadwell KK (2019) Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care 31(23):196. https:\/\/doi.org\/10.1186\/s13054-019-2478-6","journal-title":"Crit Care"},{"key":"6872_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A (2018) Sepsis and septic shock. Lancet 392:75\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(18)30696-2","journal-title":"Lancet"},{"key":"6872_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840\u2013851. https:\/\/doi.org\/10.1056\/NEJMra1208623","journal-title":"N Engl J Med"},{"key":"6872_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00134-019-05544-x","volume":"45","author":"D De Backer","year":"2019","unstructured":"De Backer D, Cecconi M, Lipman J, Machado F, Myatra SN, Ostermann M, Perner A, Teboul JL, Vincent JL, Walley KR (2019) Challenges in the management of septic shock: a narrative review. Intensive Care Med 45:420\u2013433. https:\/\/doi.org\/10.1007\/s00134-019-05544-x","journal-title":"Intensive Care Med"},{"key":"6872_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1074248419892603","volume":"25","author":"RA Kloner","year":"2020","unstructured":"Kloner RA, Shi J, Dai W, Carreno J, Zhao L (2020) Remote ischemic conditioning in acute myocardial infarction and shock states. J Cardiovasc Pharmacol Ther 25:103\u2013109. https:\/\/doi.org\/10.1177\/1074248419892603","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"6872_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41569-019-0296-9","volume":"16","author":"M Cour","year":"2019","unstructured":"Cour M, Lecour S (2019) Remote ischaemic conditioning: in search of a suitable match. Nat Rev Cardiol 16:704\u2013705. https:\/\/doi.org\/10.1038\/s41569-019-0296-9","journal-title":"Nat Rev Cardiol"},{"key":"6872_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ (2016) Yellon DM (2016) Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol 13:193\u2013209. https:\/\/doi.org\/10.1038\/nrcardio.2016.5","journal-title":"Nat Rev Cardiol"},{"key":"6872_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SHK.0000000000001362","volume":"53","author":"AFW Ho","year":"2020","unstructured":"Ho AFW, Chong J, Ong MEH, Hausenloy DJ (2020) Remote ischemic conditioning in emergency medicine\u2014clinical frontiers and research opportunities. Shock 53:269\u2013276. https:\/\/doi.org\/10.1097\/SHK.0000000000001362","journal-title":"Shock"},{"key":"6872_CR10","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.18632\/aging.101527","volume":"10","author":"D Zhou","year":"2018","unstructured":"Zhou D, Ding J, Ya J, Pan L, Wang Y, Ji X, Meng R (2018) Remote ischemic conditioning: a promising therapeutic intervention for multi-organ protection. Aging 10:1825\u20131855. https:\/\/doi.org\/10.18632\/aging.101527","journal-title":"Aging"},{"key":"6872_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00395-021-00852-0","volume":"116","author":"L Pearce","year":"2021","unstructured":"Pearce L, Davidson SM, Yellon DM (2021) Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Res Cardiol 116:12. https:\/\/doi.org\/10.1007\/s00395-021-00852-0","journal-title":"Basic Res Cardiol"},{"key":"6872_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00395-018-0672-3","volume":"113","author":"A Gaspar","year":"2018","unstructured":"Gaspar A, Louren\u00e7o AP, Pereira M\u00c1, Azevedo P, Roncon-Albuquerque R Jr, Marques J, Leite-Moreira AF (2018) Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI). Basic Res Cardiol 113:14. https:\/\/doi.org\/10.1007\/s00395-018-0672-3","journal-title":"Basic Res Cardiol"},{"key":"6872_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/eurheartj\/eht369","volume":"35","author":"AD Sloth","year":"2014","unstructured":"Sloth AD, Schmidt MR, Munk K, Kharbanda RK, Redington AN, Schmidt M, Pedersen L, S\u00f8rensen HT, B\u00f8tker HE, Investigators CONDI (2014) Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 35:168\u2013175. https:\/\/doi.org\/10.1093\/eurheartj\/eht369","journal-title":"Eur Heart J"},{"key":"6872_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0140-6736(13)61450-6","volume":"382","author":"M Thielmann","year":"2013","unstructured":"Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuh\u00e4user M, Peters J, Jakob H, Heusch G (2013) Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382:597\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(13)61450-6","journal-title":"Lancet"},{"key":"6872_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1476-9255-11-16","volume":"11","author":"YH Kim","year":"2014","unstructured":"Kim YH, Yoon DW, Kim JH, Lee JH, Lim CH (2014) Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model. J Inflamm 11:16. https:\/\/doi.org\/10.1186\/1476-9255-11-16","journal-title":"J Inflamm"},{"key":"6872_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/SHK.0000000000000526","volume":"45","author":"D Orbegozo Cort\u00e9s","year":"2016","unstructured":"Orbegozo Cort\u00e9s D, Su F, Santacruz C, Hosokawa K, Donadello K, Creteur J, De Backer D, Vincent JL (2016) Ischemic conditioning protects the microcirculation, preserves organ function, and prolongs survival in sepsis. Shock 45:419\u2013427. https:\/\/doi.org\/10.1097\/SHK.0000000000000526","journal-title":"Shock"},{"key":"6872_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jss.2016.01.033","volume":"213","author":"B Joseph","year":"2017","unstructured":"Joseph B, Khalil M, Hashmi A, Hecker L, Kulvatunyou N, Tang A, Friese RS, Rhee P (2017) Survival benefits of remote ischemic conditioning in sepsis. J Surg Res 213:131\u2013137. https:\/\/doi.org\/10.1016\/j.jss.2016.01.033","journal-title":"J Surg Res"},{"key":"6872_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00395-019-0724-3","volume":"114","author":"T Honda","year":"2019","unstructured":"Honda T, He Q, Wang F, Redington AN (2019) Acute and chronic remote ischemic conditioning attenuate septic cardiomyopathy, improve cardiac output, protect systemic organs, and improve mortality in a lipopolysaccharide-induced sepsis model. Basic Res Cardiol 114:15. https:\/\/doi.org\/10.1007\/s00395-019-0724-3","journal-title":"Basic Res Cardiol"},{"key":"6872_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13613-021-00848-y","volume":"11","author":"I Kiudulaite","year":"2021","unstructured":"Kiudulaite I, Belousoviene E, Vitkauskiene A, Pranskunas A (2021) Effects of remote ischemic conditioning on microcirculatory alterations in patients with sepsis: a single-arm clinical trial. Ann Intensive Care 11:55. https:\/\/doi.org\/10.1186\/s13613-021-00848-y","journal-title":"Ann Intensive Care"},{"key":"6872_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13063-019-3406-4","volume":"20","author":"M Cour","year":"2019","unstructured":"Cour M, Buisson M, Klouche K, Bouzgarrou R, Schwebel C, Quenot JP, Zeni F, Beuret P, Ovize M, Argaud L (2019) Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial. Trials 20:281. https:\/\/doi.org\/10.1186\/s13063-019-3406-4","journal-title":"Trials"},{"key":"6872_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"6872_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"TG Pickering","year":"2005","unstructured":"Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for Blood Pressure Measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure Research. Circulation 111:697\u2013716. https:\/\/doi.org\/10.1161\/01.CIR.0000154900.76284.F6","journal-title":"Circulation"},{"key":"6872_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2016","unstructured":"Rhodes A, Evans LE, Alhazzani W et al (2016) Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6","journal-title":"Intensive Care Med"},{"key":"6872_CR24","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963. https:\/\/doi.org\/10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"key":"6872_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira FL, Bota DP, Bross A, M\u00e9lot C, Vincent JL (2001) Serial evaluation of the SOFA Score to predict outcome in critically ill patients. JAMA 286:1754\u20131758. https:\/\/doi.org\/10.1001\/jama.286.14.1754","journal-title":"JAMA"},{"key":"6872_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B (2019) The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care 23:374. https:\/\/doi.org\/10.1186\/s13054-019-2663-7","journal-title":"Crit Care"},{"key":"6872_CR27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1001\/jama.2015.4189","volume":"313","author":"A Zarbock","year":"2015","unstructured":"Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, Haeberle H, G\u00f6rlich D, Kellum JA, Meersch M, RenalRIPC Investigators (2015) Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 313:2133\u20132141. https:\/\/doi.org\/10.1001\/jama.2015.4189","journal-title":"JAMA"},{"key":"6872_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jss.2015.06.053","volume":"200","author":"Q Hu","year":"2016","unstructured":"Hu Q, Luo W, Huang L, Huang R, Chen R, Gao Y (2016) Multiorgan protection of remote ischemic perconditioning in valve replacement surgery. J Surg Res 200:13\u201320. https:\/\/doi.org\/10.1016\/j.jss.2015.06.053","journal-title":"J Surg Res"},{"key":"6872_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jss.2013.06.058","volume":"188","author":"J Wu","year":"2014","unstructured":"Wu J, Feng X, Huang H, Shou Z, Zhang X, Wang R, Chen Y, Chen J (2014) Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial. J Surg Res 188:303\u2013308. https:\/\/doi.org\/10.1016\/j.jss.2013.06.058","journal-title":"J Surg Res"},{"key":"6872_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13054-017-1609-1","volume":"21","author":"HJ de Grooth","year":"2017","unstructured":"de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM (2017) SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care 21:38. https:\/\/doi.org\/10.1186\/s13054-017-1609-1","journal-title":"Crit Care"},{"key":"6872_CR31","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375:1638\u20131648. https:\/\/doi.org\/10.1056\/NEJMoa1609409","journal-title":"N Engl J Med"},{"key":"6872_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jama.2020.11946","volume":"324","author":"A Moskowitz","year":"2020","unstructured":"Moskowitz A, Huang DT, Hou PC, Gong J, Doshi PB, Grossestreuer AV, Andersen LW, Ngo L, Sherwin RL, Berg KM, Chase M, Cocchi MN, McCannon JB, Hershey M, Hilewitz A, Korotun M, Becker LB, Otero RM, Uduman J, Sen A, Donnino MW, ACTS Clinical Trial Investigators (2020) Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA 324:642\u2013650. https:\/\/doi.org\/10.1001\/jama.2020.11946","journal-title":"JAMA"},{"key":"6872_CR33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"AA Fowler","year":"2019","unstructured":"Fowler AA, Truwit JD, Hite RD et al (2019) Effect of vitamin C Infusion on organ failure and biomarkers of Inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA 322:1261\u20131270. https:\/\/doi.org\/10.1001\/jama.2019.11825","journal-title":"JAMA"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-022-06872-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06872-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T21:04:25Z","timestamp":1666645465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-022-06872-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6872"],"URL":"https:\/\/doi.org\/10.1007\/s00134-022-06872-1","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no conflict of interest, including financial interests, activities, relationships, and affiliations in relation with the RECO-Sepsis trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The trial was authorized by the French national drug agency on 23 August 2017 and was also approved by an Ethics Committee (Comit\u00e9 de Protection des Personnes CCP Ile-de-France X) on 5 September 2017 (n\u00b02017-A01684-49) and was registered in ClinicalTrials before the start of the study (NCT03201575). The trial was conducted according to the requirements of the Declaration of Helsinki. Written informed consent was obtained from all participants or their closest relatives (in cases of impaired decision-making capacity) at the time of enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}